Melisa Wong on Factors That Affect Lung Cancer Treatment

August 9, 2016
Melisa Wong, MD

Melisa Wong, MD, Oncology Chief Fellow, Hematology/Oncology, Aging Research T32 Fellow, University of California San Francisco Geriatrics, discusses the impact that comorbidities have on the treatment for lung cancer.

Melisa Wong, MD, Oncology Chief Fellow, Hematology/Oncology, Aging Research T32 Fellow, University of California San Francisco Geriatrics, discusses the impact that comorbidities have on the treatment for lung cancer.

In her study, Wong found that patients with comorbidities were 40% less likely to be treated for distant recurrence, yet this disparity did not exist for local-regional disease. Wong says that this is a topic that she would like to explore further.